Permanent 125iodine implants for recurrent malignant gliomas.

Gaspar, L E; Zamorano, L J; Shamsa, F; Fontanesi, J; Ezzell, G E; Yakar, D A

Gaspar, L E; Zamorano, L J; Shamsa, F; Fontanesi, J; Ezzell, G E; Yakar, D A.

Affiliation

Gaspar LE; Department of Radiation Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. gasparl@karmanos.org

Int J Radiat Oncol Biol Phys ; 43(5): 977-82, 1999 Mar 15.

Article in En | MEDLINE | ID: mdl-10192343

Subject(s)

Brain Neoplasms/radiotherapy; Glioma/radiotherapy; Iodine Radioisotopes/therapeutic use; Neoplasm Recurrence, Local/radiotherapy; Radiopharmaceuticals/therapeutic use; Adolescent; Adult; Aged; Brain Neoplasms/mortality; Female; Follow-Up Studies; Glioma/mortality; Humans; Male; Middle Aged; Neoplasm Recurrence, Local/mortality; Survival Analysis

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Brain Neoplasms / Radiopharmaceuticals / Glioma / Iodine Radioisotopes / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 1999 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links